MedPath

Hepliv

Brand Name: Hepliv

Generic Name: Hepatitis B Vaccine (rdna)

Active
Registration Number

BR-502

Dosage Form

Suspension for IM Injection

Issuance Date

October 13, 2021

Expiry Date

October 9, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100mcg/ 0.5mL
Packaging0.5ml USP Type I clear glass vial (Box of 10's)- Pediatric dose

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Vaccine
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Hepatitis B Vaccine (rdna)Active
Monograph: hepatitis b vaccine (rdna)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform